相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia
Lilliam Ambroggio et al.
PEDIATRIC PULMONOLOGY (2016)
The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia
Catia Cilloniz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Community-Acquired Pneumonia
Michael S. Niederman
ANNALS OF INTERNAL MEDICINE (2015)
Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment
Brian D. Jamieson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antimicrobial Activity of Solithromycin against Serotyped Macrolide-Resistant Streptococcus pneumoniae Isolates Collected from US Medical Centers in 2012
D. J. Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Treatment of community-acquired pneumonia
Young R. Lee et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Investment in antibiotics against pneumonia
Prabhavathi Fernandes
LANCET INFECTIOUS DISEASES (2015)
Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children's Hospitals Varies Substantially from Adult Surveillance Data in Europe
Julia Anna Bielicki et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia
Alexandra McFarlane et al.
CURRENT INFECTIOUS DISEASE REPORTS (2015)
Solithromycin to treat community-acquired pneumonia?
Ammara Mushtaq
LANCET RESPIRATORY MEDICINE (2015)
Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
Mbiye A. Mpenge et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
Investigations of Mycoplasma pneumoniae Infections in the United States: Trends in Molecular Typing and Macrolide Resistance from 2006 to 2013
Maureen H. Diaz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
W. S. Lim et al.
BMJ OPEN RESPIRATORY RESEARCH (2015)
Update on the combination effect of macrolide antibiotics in community-acquired pneumonia
M. Emmet O'Brien et al.
RESPIRATORY INVESTIGATION (2015)
Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones
Francoise Van Bambeke
ANNALS OF MEDICINE (2014)
Antimicrobial Activity of Solithromycin against Clinical Isolates of Legionella pneumophila Serogroup 1
Julia Mallegol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antibiotic Activity against Naive and Induced Streptococcus pneumoniae Biofilms in an In Vitro Pharmacodynamic Model
Nathalie M. Vandevelde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antibiotic-induced Cardiac Arrhythmias
Elsayed Abo-Salem et al.
CARDIOVASCULAR THERAPEUTICS (2014)
Pneumococcal infection in adults: burden of disease
J. J. C. Drijkoningen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review
A. Torres et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
The wobbly status of ketolides: where do we stand?
Nafsika H. Georgopapadakou
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008
Aleksandra K. Wierzbowski et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Community-acquired pneumonia in children: Current challenges and future directions
Rebecca Wallihan et al.
JOURNAL OF INFECTION (2014)
Investment in pneumonia and pneumococcal research
Michael G. Head et al.
LANCET INFECTIOUS DISEASES (2014)
The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review
Leon Peto et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2014)
β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia A Randomized Noninferiority Trial
Nicolas Garin et al.
JAMA INTERNAL MEDICINE (2014)
Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
David Oldach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae
Ward Rodgers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin
John Broad et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition
Y. Kobayashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials
K. Skalsky et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Long-term prognosis in community-acquired pneumonia
Marcos I. Restrepo et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis
M. H. Rozenbaum et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Childhood Pneumonia and Diarrhoea 1 Global burden of childhood pneumonia and diarrhoea
Christa L. Fischer Walker et al.
LANCET (2013)
Regulation of Gene Expression by Macrolide-Induced Ribosomal Frameshifting
Pulkit Gupta et al.
MOLECULAR CELL (2013)
The Changing Microbiologic Epidemiology of Community-Acquired Pneumonia
Stefano Aliberti et al.
POSTGRADUATE MEDICINE (2013)
A Novel Macrolide Solithromycin Exerts Superior Anti-inflammatory Effect via NF-κB Inhibition
Yoshiki Kobayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study
So Hyun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects
Keith A. Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
AWARE Ceftaroline Surveillance Program (2008-2010): Trends in Resistance Patterns Among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States
Michael A. Pfaller et al.
CLINICAL INFECTIOUS DISEASES (2012)
Community-acquired pneumonia in younger patients is an entity on its own
Benjamin Klapdor et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review
Alexandra Kovaleva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Clinical and economic burden of community-acquired pneumonia among adults in Europe
T. Welte et al.
THORAX (2012)
Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study
Santiago Ewig et al.
THORAX (2012)
Understanding the regulatory hurdles for antibacterial drug development in the post-Ketek world
Roger M. Echols
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
J. Gordon Still et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
Shannon D. Putnam et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Hepatic safety of antibiotics used in primary care
Raul J. Andrade et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
Patricia M. Roblin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
Daniel Bertrand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
Beatriz Llano-Sotelo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
David J. Farrell et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antimicrobial Susceptibility of Mycoplasma pneumoniae Isolates and Molecular Analysis of Macrolide-Resistant Strains from Shanghai, China
Yang Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin Comparison with Other Fluoroquinolones and Other Antibacterial Classes
Francoise Van Bambeke et al.
DRUG SAFETY (2009)
Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections
Francoise Van Bambeke et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Multidrug-resistant Streptococcus pneumoniae infections - Current and future therapeutic options
Francoise Van Bambeke et al.
DRUGS (2007)
Antibiotic drug interactions
Manjunath P. Pai et al.
MEDICAL CLINICS OF NORTH AMERICA (2006)
The burden of community-acquired pneumonia in seniors: Results of a population-based study
ML Jackson et al.
CLINICAL INFECTIOUS DISEASES (2004)
分享论文
